Search
Close this search box.

Pegcetacoplan Early Access Program for PNH

Studies

Study First Submitted Date 2021-01-25
Study First Posted Date 2021-01-28
Last Update Posted Date 2021-06-07
Verification Month Year June 2021
Verification Date 2021-06-30
Last Update Posted Date 2021-06-07

Facilities

Sequence: 198979422 Sequence: 198979423 Sequence: 198979424 Sequence: 198979425
Name Cancer Specialists of North Florida Name Tenneessee Oncology-Nashville Name Seattle Children's Hospital Name MultiCare Deaconess Cancer and Blood Specialty Center – North Spokane
City Jacksonville City Nashville City Seattle City Spokane
State Florida State Tennessee State Washington State Washington
Zip 32256 Zip 37203 Zip 98105 Zip 99204
Country United States Country United States Country United States Country United States

Conditions

Sequence: 51890829
Name Paroxysmal Nocturnal Hemoglobinuria (PNH)
Downcase Name paroxysmal nocturnal hemoglobinuria (pnh)

Id Information

Sequence: 39937825
Id Source org_study_id
Id Value EAP-PNH

Countries

Sequence: 42330436
Name United States
Removed False

Interventions

Sequence: 52207638
Intervention Type Drug
Name Pegcetacoplan
Description Complement (C3) Inhibitor

Browse Conditions

Sequence: 192356475 Sequence: 192356476 Sequence: 192356477 Sequence: 192356478 Sequence: 192356479 Sequence: 192356480 Sequence: 192356481 Sequence: 192356482 Sequence: 192356483 Sequence: 192356484 Sequence: 192356485 Sequence: 192356486 Sequence: 192356487 Sequence: 192356488 Sequence: 192356489
Mesh Term Hemoglobinuria Mesh Term Hemoglobinuria, Paroxysmal Mesh Term Proteinuria Mesh Term Urination Disorders Mesh Term Urologic Diseases Mesh Term Female Urogenital Diseases Mesh Term Female Urogenital Diseases and Pregnancy Complications Mesh Term Urogenital Diseases Mesh Term Male Urogenital Diseases Mesh Term Urological Manifestations Mesh Term Anemia, Hemolytic Mesh Term Anemia Mesh Term Hematologic Diseases Mesh Term Myelodysplastic Syndromes Mesh Term Bone Marrow Diseases
Downcase Mesh Term hemoglobinuria Downcase Mesh Term hemoglobinuria, paroxysmal Downcase Mesh Term proteinuria Downcase Mesh Term urination disorders Downcase Mesh Term urologic diseases Downcase Mesh Term female urogenital diseases Downcase Mesh Term female urogenital diseases and pregnancy complications Downcase Mesh Term urogenital diseases Downcase Mesh Term male urogenital diseases Downcase Mesh Term urological manifestations Downcase Mesh Term anemia, hemolytic Downcase Mesh Term anemia Downcase Mesh Term hematologic diseases Downcase Mesh Term myelodysplastic syndromes Downcase Mesh Term bone marrow diseases
Mesh Type mesh-list Mesh Type mesh-list Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor Mesh Type mesh-ancestor

Sponsors

Sequence: 48056397
Agency Class INDUSTRY
Lead Or Collaborator lead
Name Apellis Pharmaceuticals, Inc.

Eligibilities

Sequence: 30599330
Gender All
Minimum Age 18 Years
Maximum Age N/A
Criteria Inclusion Criteria: Patients with a confirmed diagnosis of PNH, who are transfusion dependent and are not responding to C5 treatment Exclusion Criteria: N/A
Adult True
Child False
Older Adult True

Calculated Values

Sequence: 253903650
Number Of Facilities 4
Registered In Calendar Year 2021
Were Results Reported False
Has Us Facility True
Has Single Facility False
Minimum Age Num 18
Minimum Age Unit Years

Responsible Parties

Sequence: 28721587
Responsible Party Type Sponsor